Submissions from 2024
HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani
Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia
Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani
Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia
Evaluation of a Partial Single Arc For Prostate SBRT Proton Treatment Planning According To RTOG 0938 Protocol, Suresh Rana
A Consensus Statement on the Administration of Systemic Bevacizumab in Patients with Recurrent Respiratory Papillomatosis, Geoffrey Young
Association between high risk of obstructive sleep apnea and inflammatory markers in a population sample of young and middle-aged adults in the Miami Heart Study, Atulya Khosla, Khurram Nasir, Anshul Saxena, Theodore Feldman, Jonathan Fialkow, Harneet Walia, Javier Valero-Elizondo, and Shozab Ali
Beyond “C”: A Nurse Navigator-Led Education Project to Increase Survivorship Referrals and Cancer Survivorship Attendance, Carem Irma Costa Castro, Morgan Nestingen, Tania Silva Santos, Pamela DeLongchamp, Luz Morales, Barbara Quintana, Marguerite Rowell, Merly Alonso, and Natalie Bermudez
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe
Evaluation of a non-metallic dual-port expander for intensity modulated proton therapy, Kristen McConnell, Zachary Fellows, James Kraus, Mauricio Acosta, Joseph Panoff, Eduardo Pons, Alonso Gutierrez, and Andrew Wroe
How Low Can We Go: Evaluation of a Pharmacist-led Weight Loss Management Program, Kelly Rubi, Elaina Rosario, Sara Panella, Jacqualine Igwe, Maria Pulido, and Faaria Quadri
Identification of Putative Biomarkers in Cerebral Palsy: A Meta-Analysis and Meta-Regression, Mainak Bardhan
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review, Shreyas Bellur, Reshma Mahtani, and Manmeet Ahluwalia
Impact of an Interdisciplinary Team on Patients Seen at a Heart Failure Clinic, Nilda Pelegrino, Faaria Quadri, Elaina Rosario, Jacqualine Igwe, Sandra Chaparro, Lourdes Labrada, Sara Panella, Maria Pulido, Stephen Breazeale, and Zhenwei Zhang
Improving Medical Student Performance With Unsupervised Simulation and Remote Asynchronous Feedback, Domenech Asbun
In Regard to Youssef et al, Noah Kalman and Sreenija Yarlagadda
Irreversible Electroporation in Treating Colorectal Liver Metastases in Proximity to Critical Structures, Govindarajan Narayanan, Nicole Gentile, Jonathan Eyshi, Brian Schiro, Ripal Gandhi, Constantino Pena, Antonio Ucar, Santiago Aparo, Fernando de Zarraga, Sarah Joseph, Horacio Asbun, and Madelon Dijkstra
Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement, Murugesan Manoharan and Jorge Caso
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review, Vivek Mishra, Tulika Ranjan, Arun Maharaj, and Manmeet Ahluwalia
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases, Sreenija Yarlagadda, Reshma Mahtani, Manmeet Ahluwalia, and Rupesh Kotecha
Proton Therapy for Spinal Tumors: A Consensus Statement From the Particle Therapy Cooperative Group, Robert Press